<DOC>
	<DOCNO>NCT01449877</DOCNO>
	<brief_summary>The investigator study aim determine effect prophylactic therapy Trimethoprim-sulfamethoxazole recurrence toxoplasma retinochoroiditis gondii . This randomized , double-masked , patient eye condition acute Toxoplasma gondii retinochoroiditis . Volunteers recruit previous diagnosis chorioretinitis presume Toxoplasma gondii , show active lesion compatible recurrence . After acute phase treatment patient [ 1 tablet Trimethoprim-sulfamethoxazole ( 800/160mg ) 12/12h 45 day ] , Stratified gender ) randomize 1:1 ratio group 1 - TMP-SMZ ( prophylactic treatment trimethoprim-sulfamethoxazole 1 tablet every day 311 day ) group 2 - placebo ( consist placebo pill contain active ingredient similar appearance trimethoprim-sulfamethoxazole , 1 tablet every day 311 day ) . The primary outcome incidence episode recurrent chorioretinitis toxoplasmosis follow 12 , 36 , 48 , 60 , 72 , 84 , 96 , 108 , 120 month . Patients follow ten year uveitis clinic interval define follow : return weekly 4 week , monthly 2 month , 3 month 9 month , finally annually 10 year .</brief_summary>
	<brief_title>Influence Trimethoprim-Sulfamethoxazole Recurrence Ocular Toxoplasmosis</brief_title>
	<detailed_description>The protozoan Toxoplasma gondii obligate intracellular parasite , common cause intraocular inflammation world . The treatment toxoplasmosis sulfonamide group drug , act tachyzoites form , act bradyzoites , grown latent focus locate board responsible recurrence . The investigator study aim determine effect prophylactic therapy Trimethoprim-sulfamethoxazole recurrence toxoplasma retinochoroiditis gondii . This randomized , double-masked , patient eye condition acute Toxoplasma gondii retinochoroiditis . The study population consist patient treated Ophthalmology department , University Campinas . They present symptom compatible diagnosis recurrent ocular toxoplasmosis . Volunteers recruit previous diagnosis chorioretinitis presume Toxoplasma gondii , show active lesion compatible recurrence . After acute phase treatment patient [ 1 tablet Trimethoprim-sulfamethoxazole ( 800/160mg ) 12/12h 45 day ] , Stratified gender ) randomize 1:1 ratio group 1 - TMP-SMZ ( prophylactic treatment trimethoprim-sulfamethoxazole 1 tablet every day 311 day ) group 2 - placebo ( consist placebo pill contain active ingredient similar appearance trimethoprim-sulfamethoxazole , 1 tablet every day 311 day ) . The definition patient recurrent episode chorioretinitis Toxoplasmosis presence old scar chorioretinitis , associate satellite active lesion chorioretinitis positive IgG toxoplasmosis . The new recurrence treat 1 tablet Trimethoprim-sulfamethoxazole ( 800/160mg ) 12/12h 45 day . The patient test visual acuity , examination biomicroscopy , tonometry , fundus photography indirect ophthalmoscopy . In study , patient randomize block four ( two group I two Group II ) stratification gender . The primary outcome incidence episode recurrent chorioretinitis toxoplasmosis follow 12 , 36 , 48 , 60 , 72 , 84 , 96 , 108 , 120 month . It plan minimum sample 140 patient ( 70 group I 70 group II ) . Assuming incidence 6 % recurrence group A , sample 80 % power detect difference 18 % group . The result analysis consider significant p &lt; 0.05 . The main variable age , sex , presence unilateral bilateral eye injury , number recurrence , number location lesion , previous treatment ocular toxoplasmosis . Patients follow ten year uveitis clinic interval define follow : return weekly 4 week , monthly 2 month , 3 month 9 month , finally annually 10 year . Patients trained return immediately follow symptom : decrease visual acuity , photophobia , floater ocular hyperemia . Adverse event monitor . The definition patient recurrent episode chorioretinitis Toxoplasmosis presence old scar chorioretinitis , associate active satellite lesion chorioretinitis positive IgG toxoplasmosis . To data collection , use semi-structured questionnaire , contain patient record , age , gender , visual acuity ETDRS chart , affect eye previous treatment ocular toxoplasmosis .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Toxoplasmosis , Ocular</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Positive IgG result toxoplasmosis ( IgG ) Ipsilateral scar retina compatible previous episode toxoplasmosis retinochoroiditis Unilateral active lesion chorioretinitis Under 18 year age Immunosuppressed patient Use immunosuppressive treatment Concomitant chorioretinitis cause Pregnancy Allergy Sulfonamides</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Ocular Toxoplasmosis</keyword>
	<keyword>Retinochoroiditis</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>